Atossa Therapeutics (ATOS) Return on Sales (2011 - 2016)
Atossa Therapeutics (ATOS) posted quarterly Return on Sales of 13.49% for Q3 2016, up 109.0% year-over-year from 6.46% in Q4 2015, and up 18.68% quarter-over-quarter from 16.59% in Q2 2016.
Atossa Therapeutics (ATOS) Return on Sales (2011 - 2016) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Return on Sales for 6 consecutive years, with 13.49% the latest figure, recorded in Q3 2016.
- In Q3 2016, Return on Sales rose 109.0% year-over-year to 13.49%; the TTM figure through Sep 2016 stood at 13.49% (up 109.0% YoY), while the FY2015 annual figure was 17.08%, down 1646.0% from the prior year.
- Return on Sales rose to 13.49% in Q3 2016 per ATOS's latest filing, from 16.59% in the prior quarter.
- Across five years, Return on Sales topped out at 0.08% in Q4 2013 and bottomed at 16.72% in Q1 2016.
- Historically, Return on Sales has averaged 6.8% across 5 years, with a median of 5.31% in 2012.
- Annual changes were most pronounced in 2012 — Return on Sales surged 786 bps — and 2014, when it slumped 1234 bps.
- Atossa Therapeutics' Return on Sales stood at 0.17% in 2012, then soared by 144 bps to 0.08% in 2013, then tumbled by 16188 bps to 12.26% in 2014, then fell by 10 bps to 13.49% in 2015, then changed by 0 bps to 13.49% in 2016.
- Business Quant data shows ATOS's Return on Sales at 13.49% in Q3 2016, 16.59% in Q2 2016, and 16.72% in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.00% |
| 10 | Atossa Therapeutics | 22.79 Mn | 22.79 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | -13.49% |
| Jun 30, 2016 | -16.59% |
| Mar 31, 2016 | -16.72% |
| Dec 31, 2015 | -13.49% |
| Sep 30, 2015 | -14.58% |
| Jun 30, 2015 | -10.84% |
| Mar 31, 2015 | -6.13% |
| Dec 31, 2014 | -12.26% |
| Sep 30, 2014 | -9.47% |
| Jun 30, 2014 | -3.23% |
| Mar 31, 2014 | -1.00% |
| Dec 31, 2013 | 0.08% |
| Sep 30, 2013 | -0.49% |
| Jun 30, 2013 | -0.21% |
| Mar 31, 2013 | -1.44% |
| Dec 31, 2012 | -0.17% |
| Sep 30, 2012 | -0.11% |
| Jun 30, 2012 | -3.74% |
| Mar 31, 2012 | -5.31% |
| Dec 31, 2011 | -8.04% |